{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/06/15/3311760/0/en/Polyrizon-Advances-NASARIX-Development-with-Key-Human-Study-to-Characterize-Nasal-Residence-Time-and-Support-FDA-Regulatory-Pathway.html", "message": "News view counter 798845 successfully enlarged"}